2022
DOI: 10.1111/cen.14680
|View full text |Cite
|
Sign up to set email alerts
|

The occurrence of hypogonadotropic hypogonadism in Chinese men with type 2 diabetes

Abstract: Context The previous studies showed that hypogonadotropic hypogonadism (HH) occurred commonly in men with type 2 diabetes. However, since all the cohorts tested were from American and European studies, the occurrence of HH/nongonadal illness (NGI) in Chinese populations is unclear. Objective The study aimed to explore the occurrence of HH/NGI in Chinese men with type 2 diabetes. Furthermore, the correlative factors and predictors of hypogonadism were investigated. Design We conducted a cross‐sectional study of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 55 publications
(180 reference statements)
0
0
0
Order By: Relevance
“…Pre-testicular mechanisms involve central as well as peripheral hypogonadism, leading to decreased serum levels of gonadotropins, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and testosterone (T) [14,15]. Indeed, high incidence of hypogonadism has been previously reported among type 2 diabetic men [16][17][18][19]. Moreover, a large amount of pre-clinical and clinical evidence supports substantial association between DM-related metabolic derangements and reduced serum testosterone levels [20,21].…”
Section: Introductionmentioning
confidence: 98%
“…Pre-testicular mechanisms involve central as well as peripheral hypogonadism, leading to decreased serum levels of gonadotropins, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and testosterone (T) [14,15]. Indeed, high incidence of hypogonadism has been previously reported among type 2 diabetic men [16][17][18][19]. Moreover, a large amount of pre-clinical and clinical evidence supports substantial association between DM-related metabolic derangements and reduced serum testosterone levels [20,21].…”
Section: Introductionmentioning
confidence: 98%